BIO leader hits proposal for drug price regulation The Cambridge-based chairman of the nation’s largest biotech organization is strongly opposing […]

Biotech industry in survival mode Restructuring, retrenching and reinventing themselves, Bay Area biotechnology firms are adapting to weather the economic

The genetically-modified food fight Once again, Europe and the U.S. are at loggerheads. This time, they’re fighting over food, not

No simple generic answer Unlike pills and capsules that are brewed from a mixture of chemicals, injectable therapies like hormones

Antibacterials: a dying trade : Despite strong worldwide demand for effective antibacterial products, sustaining growth within this segment will become

Financial Snapshot For June 2003: Taking A Breather

Pfizer’s Quest to Stay Ahead of the Pack The drugmaker has been a stable holding in unstable times. Now, though,

Pfizer’s Quest to Stay Ahead of the Pack The drugmaker has been a stable holding in unstable times. Now, though,

Can Your Genomics Work Contribute to Biodefense Three years ago, Luis Villarreal, a virologist at the University of California, Irvine,

Biogen/Idec: still a matter of size The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help